✨ Your Portfolio is fetched and updated from zerodha.

Mankind Pharma Ltd.

MANKIND

Market Cap
₹1,02,273 Cr.
P/E
48.36

Mankind Pharma Ltd.

About
Mankind Pharma Limited is a company involved in the development, manufacturing, and marketing of pharmaceutical formulations across various therapeutic areas, along with consumer healthcare products i… Read more
Mankind Pharma Limited is a company involved in the development, manufacturing, and marketing … Read more
Low
1821
52W Range
High
2874
  • Mankind Pharma
  • Dr. Reddy's Lab
  • Torrent Pharma

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates
Custom financial statementNew
Edit rows
Forensics

8 Yes

Positive for this company

3 Neutral

Neutral for this company

5 No

Negative for this company

1 No Data

Insufficient data to analyse

Market Share
0 %
(as of Mar 22)
Historic
Anti Fungal Antibiotics (Terbinaforce) - Market Share
0 %
(as of Mar 22)
Historic
Anti-Hypertensives (Amolkind-AT) Market Share
60 %
(as of Jun 23)
Historic
Birth Control (Unwanted-72) - Market Share
0 %
(as of Mar 21)
Historic
Depression (Placida) - Market Share
0 %
(as of Mar 21)
Historic
Gastrointestinal (Nurokind-LC) - Market Share
Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Location Wise Break-Up - Domestic Sales

Acute vs Chronic

Brand Wise Break-Up

Operational Metrics

    locked
    Select a Metric
    • Number of ANDA's Filed in USA (.)
      Source
    • Number of ANDA's Approved By USFDA (.)
      Source
    • Advertisement Spend as a % of Total Sales (%)
      Source
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    FAQs on Mankind Pharma Ltd. Business

    Mankind Pharma Limited is an Indian company specializing in pharmaceutical formulations and consumer healthcare products. It emphasizes quality offerings at affordable prices, successfully building several in-house brands.

    Mankind Pharma major competitors are Torrent Pharma, Dr. Reddy's Lab, Zydus Lifesciences, Lupin, Cipla, Aurobindo Pharma, Alkem Laboratories.
    Market Cap of Mankind Pharma is ₹1,04,413 Crs.
    While the median market cap of its peers are ₹96,402 Crs.

    Mankind Pharma seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    View FAQ's On Shareprice
    Company Filing
    2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Mar Jun Sep Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Investor Presentation Mar Jun Sep Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call Mar Jun Sep Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call SummaryCon Call Summary Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Discussions & Analysis
    Mankind Pharma Ltd.
    Interview With Mankind’s Founder Rajeev Juneja - Ranveer Allahbad
    timeline Timeline